2024
Parent-Only Treatment of Children and Adolescents
Etkin R, Shimshoni Y, Lebowitz E. Parent-Only Treatment of Children and Adolescents. CBT: Science Into Practice 2024, 207-228. DOI: 10.1007/978-3-031-74838-7_9.Peer-Reviewed Original ResearchAdolescent obsessive-compulsive disorderObsessive-compulsive disorderTreatment of childrenIllustrative case vignetteEtiology of childrenAnxious distressChildhood anxietyAnxiety disordersChild anxietyParental behavior changeAccommodation behaviorAnxietyCase vignettesSupportive responsesBehavioral changesCultural considerationsTreatment approachesDisordersChildrenParentsEmpirical researchSystems perspectiveAdolescentsDistressVignettes
2023
Children's Oncology Group's 2023 blueprint for research: Surgery
Gow K, Lautz T, Malek M, Cost N, Newman E, Dasgupta R, Christison‐Lagay E, Tiao G, Davidoff A, Committee T. Children's Oncology Group's 2023 blueprint for research: Surgery. Pediatric Blood & Cancer 2023, 71: e30766. PMID: 37950538, PMCID: PMC10872730, DOI: 10.1002/pbc.30766.Peer-Reviewed Original ResearchImproving Substance Use Prevention, Assessment, and Treatment Financing to Enhance Equity and Improve Outcomes Among Children, Adolescents, and Young Adults
Camenga D, Hammer L. Improving Substance Use Prevention, Assessment, and Treatment Financing to Enhance Equity and Improve Outcomes Among Children, Adolescents, and Young Adults. 2023, 148-157. DOI: 10.1542/9781610027052-part01-improving.Peer-Reviewed Original ResearchClinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity
Hampl S, Hassink S, Skinner A, Armstrong S, Barlow S, Bolling C, Avila Edwards K, Eneli I, Hamre R, Joseph M, Lunsford D, Mendonca E, Michalsky M, Mirza N, Ochoa E, Sharifi M, Staiano A, Weedn A, Flinn S, Lindros J, Okechukwu K. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. 2023, 25-124. DOI: 10.1542/9781610027052-part01-clinical.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsKey action statementsMost effective careClinical practice guidelinesTreatment of childrenExpert consensus recommendationsPractice guidelinesConsensus recommendationsEffective careMeticulous careObesityAction statementsCurrent literatureCareTreatmentChildrenGuidelinesSubcommittee membersAdolescentsAppropriate emphasisOverweightMonthsMorbidity and Mortality in Neonates with Symptomatic Congenital Lung Malformation.
Engwall-Gill A, Weller J, Salvi P, Penikis A, Sferra S, Rhee D, Solomon D, Kunisaki S. Morbidity and Mortality in Neonates with Symptomatic Congenital Lung Malformation. Journal Of The American College Of Surgeons 2023, 236: 1139-1146. PMID: 36786474, DOI: 10.1097/xcs.0000000000000653.Peer-Reviewed Original ResearchConceptsCongenital lung malformationsExtracorporeal membrane oxygenationPostoperative length of stayLength of stayNeonatal resectionLung malformationsLung resectionMechanical ventilationCLM patientsExtracorporeal membrane oxygenation rescueMedian postoperative length of stayCongenital pulmonary airway malformationPediatric Health Information System databasePreoperative mechanical ventilationRespiratory complication rateHealth Information System databaseCardiac structural anomaliesPostoperative respiratory complicationsCongenital lobar emphysemaEvaluate risk factorsPrimary outcome measureTreatment of childrenAirway malformationBronchopulmonary sequestrationCardiac structural diseaseClinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity.
Hampl S, Hassink S, Skinner A, Armstrong S, Barlow S, Bolling C, Avila Edwards K, Eneli I, Hamre R, Joseph M, Lunsford D, Mendonca E, Michalsky M, Mirza N, Ochoa E, Sharifi M, Staiano A, Weedn A, Flinn S, Lindros J, Okechukwu K. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. 2023, 151 PMID: 36622115, DOI: 10.1542/peds.2022-060640.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsExecutive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity.
Hampl S, Hassink S, Skinner A, Armstrong S, Barlow S, Bolling C, Avila Edwards K, Eneli I, Hamre R, Joseph M, Lunsford D, Mendonca E, Michalsky M, Mirza N, Ochoa E, Sharifi M, Staiano A, Weedn A, Flinn S, Lindros J, Okechukwu K. Executive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. 2023, 151 PMID: 36622135, DOI: 10.1542/peds.2022-060641.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsChapter 19 Working with parents in the treatment of child and adolescent anxiety
Etkin R, Lebowitz E, Silverman W. Chapter 19 Working with parents in the treatment of child and adolescent anxiety. 2023, 341-358. DOI: 10.1016/b978-0-323-99613-6.00003-x.ChaptersAnxiety treatmentAdolescent anxietyAnxiety disordersChild anxiety treatmentIndividual child treatmentsAdolescent anxiety disordersExtant evidence baseParent variablesTreatment literatureChild's treatmentParent involvementParents' roleTreatment of childrenTheoretical importanceConsiderable methodological variationsEtiology of childrenMethodological variationsAnxietyParentsChildrenInvolvement approachEvidence baseValid inferencesConcrete recommendationsRich literature
2022
Cholecystitis and Gallstone Disease
Maassel N, Stitelman D. Cholecystitis and Gallstone Disease. 2022, 837-841. DOI: 10.1007/978-3-031-07524-7_90.Peer-Reviewed Original ResearchLow gallbladder ejection fractionLimited hospital stayMost surgical candidatesPediatric laparoscopic cholecystectomyAbsence of gallstonesGallbladder ejection fractionNuclear medicine scansTreatment of childrenBiliary colicBiliary dyskinesiaHospital stayComplicated cholecystitisSurgical candidatesEjection fractionGallstone diseaseLaparoscopic cholecystectomyMotility disordersBlood testsPhysical examinationChronic hemolytic diseaseHemolytic diseaseFocused historyPediatric specialistsObesity ratesCholecystitisImproving Substance Use Prevention, Assessment, and Treatment Financing to Enhance Equity and Improve Outcomes Among Children, Adolescents, and Young Adults.
Camenga DR, Hammer LD. Improving Substance Use Prevention, Assessment, and Treatment Financing to Enhance Equity and Improve Outcomes Among Children, Adolescents, and Young Adults. 2022, 150 PMID: 35757960, DOI: 10.1542/peds.2022-057992.Peer-Reviewed Original Research
2020
Stiripentol fails to lower plasma oxalate in a dialysis-dependent PH1 patient
Kempf C, Pfau A, Holle J, Müller-Schlüter K, Bufler P, Knauf F, Müller D. Stiripentol fails to lower plasma oxalate in a dialysis-dependent PH1 patient. Pediatric Nephrology 2020, 35: 1787-1789. PMID: 32418144, PMCID: PMC7385015, DOI: 10.1007/s00467-020-04585-5.Peer-Reviewed Original ResearchConceptsEnd-stage renal diseaseChronic kidney diseaseLactate dehydrogenase 5Urinary oxalateAdvanced chronic kidney diseaseAnti-convulsive drugsMultisystemic metabolic disorderLiver-kidney transplantationMajority of patientsCurrent standard treatmentTreatment of childrenHyperoxaluria type 1Anuric infantsPH patientsUox excretionRenal diseaseDravet syndromeKidney diseasePrimary hyperoxaluriaCompassionate useStandard treatmentPlasma concentrationsMetabolic disordersPromising drugEarly infancyManagement and treatment of nocturnal enuresis—an updated standardization document from the International Children's Continence Society
Nevéus T, Fonseca E, Franco I, Kawauchi A, Kovacevic L, Nieuwhof-Leppink A, Raes A, Tekgül S, Yang S, Rittig S. Management and treatment of nocturnal enuresis—an updated standardization document from the International Children's Continence Society. Journal Of Pediatric Urology 2020, 16: 10-19. PMID: 32278657, DOI: 10.1016/j.jpurol.2019.12.020.Peer-Reviewed Original ResearchConceptsInternational Children's Continence SocietyInternational Children's Continence Society membersConcomitant sleep-disordered breathingFirst-line treatment modalitySleep-disordered breathingUrinary tract infectionTreatment of childrenNonmonosymptomatic enuresisAntidepressant treatmentDisordered breathingMonosymptomatic enuresisSleep apneaUrodynamic assessmentDaytime incontinenceAnticholinergic treatmentFirst-lineTract infectionsTreatment modalitiesAirway obstructionBlood testsActive therapyEvidence-based literatureEnuretic childrenEnuresis alarmComorbid conditions
2019
Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group
Kelly KM, Cole PD, Pei Q, Bush R, Roberts KB, Hodgson DC, McCarten KM, Cho SY, Schwartz C. Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group. British Journal Of Haematology 2019, 187: 39-48. PMID: 31180135, PMCID: PMC6857800, DOI: 10.1111/bjh.16014.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAntineoplastic Combined Chemotherapy ProtocolsBleomycinChildChild, PreschoolCyclophosphamideDoxorubicinDrug Administration ScheduleDrug MonitoringEtoposideFemaleHodgkin DiseaseHumansIfosfamideMaleNeoplasm StagingPositron-Emission TomographyPrednisoneProspective StudiesRadiotherapy, AdjuvantRecurrenceTreatment OutcomeVincristineVinorelbineYoung AdultConceptsHigh-risk Hodgkin lymphomaABVE-PCOncology GroupHodgkin's lymphomaEarly respondersRapid early respondersEnd of chemotherapyEvent-free survivalOverall survival rateResponse-adapted therapyChildren's Oncology GroupTreatment of childrenPET-positive lesionsAlkylator exposureOS ratesActive diseaseTreat analysisPediatric patientsRadiotherapy volumeClinical evidenceEarly progressionRadiation volumeRecent trialsPositive lesionsSER patients
2017
Clinical trials: Kids are not just little people
Naka F, Strober B, Shahriari M. Clinical trials: Kids are not just little people. Clinics In Dermatology 2017, 35: 583-593. PMID: 29191349, DOI: 10.1016/j.clindermatol.2017.08.008.Peer-Reviewed Original ResearchRisk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis.
Stuckelman ZD, Mulqueen JM, Ferracioli-Oda E, Cohen SC, Coughlin CG, Leckman JF, Bloch MH. Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis. The Journal Of Clinical Psychiatry 2017, 78: e648-e655. PMID: 28682529, DOI: 10.4088/jcp.15r10601.Peer-Reviewed Original ResearchConceptsAttention-deficit/hyperactivity disorderRisk of irritabilitySide effectsPsychostimulant medicationPsychostimulant treatmentAmphetamine derivativesPlacebo-controlled trialCommon side effectsStratified subgroup analysisEffects of amphetamineTreatment of childrenDuration of usePsychostimulant classesEligible trialsMedical comorbiditiesHead trialsSubgroup analysisRisk ratioRelative riskSTUDY SELECTIONEffective treatmentData sourcesPubMed searchTrial designStimulant type
2016
Cholecystitis
Tackett J, Cowles R. Cholecystitis. 2016, 641-645. DOI: 10.1007/978-3-319-27443-0_80.ChaptersLimited hospital stayMost surgical candidatesPediatric laparoscopic cholecystectomyTreatment of childrenHospital stayComplicated cholecystitisSurgical candidatesLaparoscopic cholecystectomyBlood testsPhysical examinationChronic hemolytic diseaseHemolytic diseaseFocused historyPediatric specialistsObesity ratesCholecystitisCholecystectomyStayDiseaseIncidenceReducing Therapist Contact in Parenting Programs: Evaluation of Internet-Based Treatments for Child Conduct Problems
Rabbitt SM, Carrubba E, Lecza B, McWhinney E, Pope J, Kazdin AE. Reducing Therapist Contact in Parenting Programs: Evaluation of Internet-Based Treatments for Child Conduct Problems. Journal Of Child And Family Studies 2016, 25: 2001-2020. PMID: 27453678, PMCID: PMC4956080, DOI: 10.1007/s10826-016-0363-3.Peer-Reviewed Original ResearchParent management trainingConduct problemsTherapist contactTherapeutic allianceChild conduct problemsOverall adaptive functioningPositive treatment outcomesMental health professionalsAdaptive functioningInternet-based versionParenting ProgramExternalizing symptomsAntisocial behaviorParents' adherenceParents' reactionsTreatment of childrenManagement trainingPerson treatmentTreatment outcomesSixty childrenSupplementary analysisTherapistsChildrenHealth professionalsTreatment groups
2015
Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed Very High Risk Hodgkin Lymphoma (Stages IIIB/IVB) (AHOD0831): A Report from the Children's Oncology Group
Kelly K, Cole P, Chen L, Roberts K, Hodgson D, McCarten K, Cho S, Schwartz C. Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed Very High Risk Hodgkin Lymphoma (Stages IIIB/IVB) (AHOD0831): A Report from the Children's Oncology Group. Blood 2015, 126: 3927. DOI: 10.1182/blood.v126.23.3927.3927.Peer-Reviewed Original ResearchHigh-risk Hodgkin lymphomaRapid early responseCompletion of chemotherapyABVE-PCStage IIIBOncology GroupOverall survivalPediatric patientsHodgkin's lymphomaHigh riskLong-term overall survivalDose-intensive chemotherapyRisk-adapted radiotherapyEnd of chemotherapyEvent-free survivalBone marrow involvementPhase III studyRelapse/progressionBest predictive factorChildren's Oncology GroupHigh-risk groupEnhanced risk stratificationTreatment of childrenPET-positive lesionsBulky involvementMeta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder
Coughlin CG, Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Bloch MH. Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder. Journal Of Child And Adolescent Psychopharmacology 2015, 25: 611-617. PMID: 26402485, PMCID: PMC4617411, DOI: 10.1089/cap.2015.0075.Peer-Reviewed Original ResearchConceptsRisk of anxietyAttention-deficit/hyperactivity disorderPsychostimulant treatmentSide effectsHyperactivity disorderPlacebo-controlled trialStratified subgroup analysisTreatment of childrenDuration of useRisk ratioSubgroup analysisPsychostimulant medicationPlaceboPubMed searchTrial designNumber of childrenHigh dosesStimulant typePsychostimulantsAnxiety symptomsTreatmentChildrenRiskSymptomsAnxietyMeta-Analysis: Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled Trials
Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Coughlin CG, Leckman JF, Bloch MH. Meta-Analysis: Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled Trials. Journal Of The American Academy Of Child & Adolescent Psychiatry 2015, 54: 728-736. PMID: 26299294, DOI: 10.1016/j.jaac.2015.06.011.Peer-Reviewed Original ResearchConceptsWorsening of ticsRisk of ticsAttention-deficit/hyperactivity disorderPlacebo-controlled trialNew onsetDuration of treatmentPsychostimulant usePsychostimulant medicationNew-onset ticsType of psychostimulantsParallel-group trialStratified subgroup analysisSide effect dataTreatment of childrenAge of participantsPlacebo groupAdverse eventsCrossover studyPsychostimulant treatmentTic symptomsRisk ratioSubgroup analysisFamily historyGroup trialsPubMed search
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply